报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 14.38% | -32.36% | 47.79% | 5/128 | 4.74% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 9.73% | -32.38% | 115.74% | 6/128 | 3.02% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 4.51% | -35.57% | -81.82% | 10/128 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 24.81% | 23.07% | 16.7% | 3/128 | 4.98% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 21.26% | 13.21% | 47.74% | 3/128 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 14.39% | 12.95% | 105.57% | 2/128 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 7% | -11.62% | -65.28% | 5/128 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 20.16% | -5.13% | 7.35% | 25/128 | 13.37% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 18.78% | -0.05% | 47.41% | 25/128 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 12.74% | -6.73% | 60.86% | 22/128 | 9.31% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 7.92% | 0.13% | -62.73% | 17/128 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 21.25% | 28.01% | 13.09% | 36/128 | 17.51% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 18.79% | 32.32% | 37.55% | 28/128 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 13.66% | 40.68% | 72.69% | 29/128 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 7.91% | 45.67% | -52.35% | 18/128 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 16.6% | -21.36% | 16.9% | 58/128 | 25.89% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 14.2% | -46.62% | 46.24% | 42/128 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 9.71% | -68.72% | 78.82% | 45/128 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2020-03-31 | 5.43% | 2% | -74.28% | 16/128 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
2019-12-31 | 21.11% | -54.43% | -20.64% | 36/128 | 14.36% | 健尔康 | 84.09% | 行业排名> |
2019-09-30 | 26.6% | 2% | -14.3% | 2/128 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
2019-06-30 | 31.04% | 2% | -32.99% | 1/128 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
2018-12-31 | 46.32% | 2% | 2% | 2/128 | 12.98% | 新华医疗 | 13.55% | 行业排名> |